| Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291) |
|---|
| 01/29/2009 | WO2009012596A1 Substituted aryl-fluoroborates as imaging agents |
| 01/29/2009 | WO2007095749A8 Cytotoxicity mediation of cells evidencing surface expression of trop-2 |
| 01/29/2009 | US20090030308 Systems, compositions, and methods for local imaging and treatment of pain |
| 01/29/2009 | US20090028867 Antagonists Specific For Denatured Collagen And Methods Of Using Same |
| 01/29/2009 | US20090028791 Dichloroacetate Analogs as Imaging Agents |
| 01/29/2009 | US20090028790 Labelled adrenomedullin derivatives and their use for imaging and therapy |
| 01/29/2009 | US20090028789 Methods for detecting parenchymal plaques in vivo |
| 01/29/2009 | US20090028788 Compounds having rd targeting motifs |
| 01/29/2009 | US20090028786 Methods and apparatus for imaging agents for disease detection |
| 01/29/2009 | US20090028785 Medical devices with coatings for delivery of a therapeutic agent |
| 01/29/2009 | US20090028784 Antibodies to IL-6 and use thereof |
| 01/29/2009 | CA2731645A1 Substituted aryl-fluoroborates as imaging agents |
| 01/29/2009 | CA2694582A1 New compositions based on polysaccharides grafted by polyamine or polysulphurised compounds |
| 01/28/2009 | EP2019103A1 Novel compound having affinity for amyloid |
| 01/28/2009 | EP2018173A1 Magnetorheological fluids and therapeutic uses thereof |
| 01/28/2009 | EP1624902B1 Methods of producing carbon-13 labeled biomass |
| 01/28/2009 | EP1470129B1 Radiolabeled neuropeptide y y5 receptor antagonists |
| 01/28/2009 | CN101355940A In vivo or in vitro method for detecting amyloid deposits having at least one amyloidogenic protein |
| 01/28/2009 | CN100455598C Antibody of anti human CD20 from human resources functionally, and application |
| 01/28/2009 | CN100455574C Thiazoline acid derivatives |
| 01/27/2009 | US7482498 Synthesis of a radioactive 18-fluorine isotope-labeled imaging compound using a positron emission tomograph or magnetic resonance; more flexible results by placing the anion exchange device partially in the measurement chamber to measure [18F]fluoride ions in the anion exchange device; efficiency |
| 01/27/2009 | US7481993 conjugate PT comprising(a) a peptide P and(b) a targeting moiety T;wherein the peptide P contains from 4 to 20 amino acid residues with optionally a single thiol moiety at the C- or N-terminus replacing one of these amino acid residues, and including a complexing amino acid sequence |
| 01/27/2009 | CA2438168C Modulated release particles for aerosol delivery |
| 01/27/2009 | CA2191951C Monoamine, diamide, thiol-containing metal chelating agents |
| 01/22/2009 | WO2009012288A2 Trifunctional imaging agent for monoclonal antibody tumor-targeted imaging |
| 01/22/2009 | WO2009011589A1 A microsphere comprising an organic lanthanide metal complex |
| 01/22/2009 | WO2009009883A1 An anti-cancer cytotoxic monoclonal antibody |
| 01/22/2009 | WO2009009882A1 An anti-cancer cytotoxic monoclonal antibody |
| 01/22/2009 | WO2009009881A1 An anti-cancer cytotoxic monoclonal antibody |
| 01/22/2009 | WO2008079834A3 Preparation of paramagnetic nanoparticles conjugated to leukotriene b4 (ltb4) receptor antagonists, and their use as mri contrast agents for the detection of infection and inflammation |
| 01/22/2009 | WO2007148074A8 Chemical methods and apparatus |
| 01/22/2009 | US20090024108 Methods and Devices for Delivery of Compositions to Conduits |
| 01/22/2009 | US20090023787 Technetium-dipyridine complexes, and methods of use thereof |
| 01/22/2009 | US20090023651 Inhibitors of human plasmin derived from the kunitz domains |
| 01/22/2009 | US20090023160 Antibodies specific for CYP1B1 |
| 01/22/2009 | US20090022664 Radiolabelling via fluorination of aziridines |
| 01/22/2009 | US20090022663 Antibodies and related molecules that bind to 161p2f10b proteins |
| 01/22/2009 | US20090022662 Cancerous disease modifying antibodies |
| 01/22/2009 | US20090022661 Cancerous disease modifying antibodies |
| 01/22/2009 | US20090022660 Monoclonal antibodies comprising cytotoxic agent capable of inducing antibody dependent cellular cytotoxicity directed towards tumorus tissues |
| 01/22/2009 | US20090022659 Antibodies to TNF alpha and use thereof |
| 01/22/2009 | US20090022658 Modified antibodies and methods of use |
| 01/22/2009 | US20090022657 Novel CXCL8 antagonists |
| 01/22/2009 | US20090022656 Lipidated glycoprotein particles and methods of use |
| 01/22/2009 | US20090022655 boron neutron capture therapy, attaching antibody (IgG) cell-targeting species to BN nanostructures to form composite, administering to target tumors, activating boron in composite; indirect source of radiation therapy, delivery vehicles for radio- and chemo-therapeutic materials, imaging agents |
| 01/22/2009 | DE102007033020A1 Bispidonliganden und deren Metallkomplexe Bispidone ligands and metal complexes thereof |
| 01/22/2009 | CA2694003A1 A microsphere comprising an organic lanthanide metal complex |
| 01/22/2009 | CA2692912A1 An anti-cancer cytotoxic monoclonal antibody |
| 01/22/2009 | CA2692826A1 An anti-cancer cytotoxic monoclonal antibody |
| 01/22/2009 | CA2692823A1 An anti-cancer cytotoxic monoclonal antibody |
| 01/21/2009 | EP2017359A2 Method for the elution of 18F fluoride trapped on an anion-exchange resin in a form suitable for efficient radiolabeling without any evaporation step |
| 01/21/2009 | EP2017253A1 A particle comprising an organic lanthanide metal complex |
| 01/21/2009 | EP2015785A2 Agrm2 antigen |
| 01/21/2009 | EP2015775A1 Combination of an anti edb fibronectin domain antibody l19-sip and an anti-egfr antibody |
| 01/21/2009 | EP1585770B1 Recognition molecules for the treatment and detection of tumours |
| 01/21/2009 | EP1560600B1 Method for the selective and quantitative functionalization of immunoglobulin fab fragments, conjugate compounds obtained with the same and compositions thereof |
| 01/21/2009 | EP0975760B1 Motilin homologs |
| 01/21/2009 | CN101347626A Vascularized specific polypeptide for marking tumor by radioactive nucleus and uses thereof |
| 01/21/2009 | CN101347623A Multifunctional nanodevice platform |
| 01/20/2009 | US7479376 Using caudal-1 gene (CDX-1) as diagnostic indicator of stomach or esophageal cancer; immunodiagnostics |
| 01/15/2009 | WO2009008988A1 Immunostimulating polyphosphazene compounds for intradermal immunization |
| 01/15/2009 | WO2008143706A3 Daa peripheral benzodiazepine receptor ligand for cancer imaging and treatment |
| 01/15/2009 | WO2008073160A3 Methods for converting or inducing protective immunity |
| 01/15/2009 | US20090019555 increased lung mucus retention and its genome comprises a promoter linked to a heterologous DNA encoding an epithelial sodium channel subunit; useful in treatment of bronchitis and asthma; drug screening |
| 01/15/2009 | US20090016958 Nucleoside based proliferation imaging markers |
| 01/15/2009 | US20090016957 Polypeptides |
| 01/15/2009 | US20090016956 Labeled Macrophages and Methods of Use Thereof |
| 01/15/2009 | CA2692740A1 Immunostimulating polyphosphazene compounds for intradermal immunization |
| 01/14/2009 | EP2014310A2 KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy |
| 01/14/2009 | EP2012937A2 Systems and methods for producing multilayered particles, fibers and sprays and methods for administering the same |
| 01/14/2009 | EP2012833A2 Radiolabeled dihydrotetrabenazine derivatives and their use as imaging agents |
| 01/14/2009 | EP2012791A2 7,9-dihydro-purin-8-one and related analogs as hsp90-inhibitors |
| 01/14/2009 | EP1919517B1 Radiolabelled nanoparticles |
| 01/14/2009 | EP1536843A4 Radiolabeled compounds and liposomes and their methods of making and using the same |
| 01/14/2009 | EP1456386B1 Polycistronic expression of antibodies in cho cells |
| 01/14/2009 | EP1297142B1 Dual specificity antibodies and methods of making and using |
| 01/14/2009 | EP1146913B1 Conjugates of granulocyte colony stimulating factors for targeting and imaging infection and inflammation |
| 01/14/2009 | CN101346392A Process for production of compound labeled with radioactive fluorine |
| 01/14/2009 | CN101346391A Process for production of compound labeled with radioactive fluorine |
| 01/14/2009 | CN100450553C Degradable radioactive sponge and its making process |
| 01/13/2009 | US7476657 Appear to function at least in part by inhibiting G2 cell cycle checkpoint; useful in treating metastatic and non-metastatic solid or liquid tumors |
| 01/13/2009 | US7476377 Rubidium-82 generator based on sodium nonatitanate support, and improved separation methods for the recovery of strontium-82 from irradiated targets |
| 01/13/2009 | CA2238860C Stereoisomers of fatty acid analogs for diagnostic imaging |
| 01/13/2009 | CA2185653C Stabilization of peptides and proteins for radiopharmaceutical use |
| 01/08/2009 | WO2009006227A1 Radiolabeled compounds and uses thereof |
| 01/08/2009 | WO2009005509A1 Near infrared-fluorescence using phospholipid ether analog dyes in endoscopic applications |
| 01/08/2009 | WO2008107471A3 Modified hydroxypolymer conjugates with killing effect on tumor cells |
| 01/08/2009 | WO2008040441A3 Silicon derivatives for pet imaging |
| 01/08/2009 | US20090012090 Radiohalogenated Benzamide Derivatives And Their Use In Tumor Diagnosis And Tumor Therapy |
| 01/08/2009 | US20090010935 Compositions and Methods of Treating Tumors |
| 01/08/2009 | US20090010848 Recombinant Peptides Derived from the Mc3 Anti-BA46 Antibody, Methods of Use Thereof, and Methods of Humanizing Antibody Peptides |
| 01/08/2009 | US20090010846 Nitro-Imidazole Hypoxia Imaging Agents |
| 01/08/2009 | US20090010845 Polybiotin Compounds of Magnetic Resonance Imaging and Drug Delivery |
| 01/08/2009 | US20090010844 Imaging Infection With Compounds That Bind to Thymidine Kinase |
| 01/08/2009 | US20090010843 Methods of Identifying Antibodies to Ligands of Orphan Receptors |
| 01/08/2009 | US20090010842 Methods for the early diagnosis of ovarian cancer |
| 01/08/2009 | US20090010841 Antiproliferative agents; as chimeric molecules to direct an effector (e.g. a cytotoxin, an imaging reagent, a drug, etc.) to a prostate tumor site; single chain antibody |
| 01/08/2009 | US20090010840 BISPECIFIC SINGLE CHAIN Fv ANTIBODY MOLECULES AND METHODS OF USE THEREOF |
| 01/08/2009 | US20090010839 Avidin dimers effective in increasing the concentration of radioactive biotin in pretargeted radioimmunotherapy |
| 01/08/2009 | US20090010838 Pyridylacetylenes for Use as Radiotracers and Imaging Agents |